Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Incontinence & Intimate Partners: Assessing the Contribution of Treatment (IIMPACT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Elizabeth Mueller, Loyola University
ClinicalTrials.gov Identifier:
NCT01559389
First received: March 15, 2012
Last updated: October 5, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)